CXCL9 and CXCL11 Levels in Patients With Autoimmune Thyroiditis and Habitual Abortions
This trial is active, not recruiting.
|Sponsor||Ankara Education and Research Hospital|
|Trial identifier||NCT01644318, 3848|
The purpose of this study is to measure serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions
|Observational model||case control|
Serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions
Female participants from 20 years up to 40 years old.
- non-pregnant women with euthyroid autoimmune thyroiditis and a history of first trimester recurrent spontaneous abortions
- 1) presence of acute or chronic systemic diseases; 2) other autoimmune diseases; 3) pregnancy and lactation over the previous 6 months; 4) evidence of infectious diseases in the last 3 months; 5) treatment with drugs known to interfere with cytokine release, such as corticosteroids, immunosuppressors, or nonsteroidal antiinflammatory drugs, amiodarone, and lithium; 6) clinical history of hyperthyroidism and/or the presence of anti-TSH receptor antibodies.
Call for more information